Paul J Clancy
CIK 1409601 · EVP, Chief Financial Officer · last filed 2026-06-10
Paul J Clancy is an EVP, Chief Financial Officer who has filed 132 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for INCY, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$50.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.11M
6
132
-$49.98M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INCY | Director | 25,383 | $108.53 | $2.75M | -$1.42M | 43 | 2026-06-10 |
| EXACT SCIENCES CORP (EXAS) Delisted | Director | 0 | $104.91 | $0 | $0 | 8 | 2026-03-23 |
| SION | Director | — | $35.92 | — | $0 | 1 | 2025-06-16 |
| XLO | Director | — | $8.31 | — | $0 | 5 | 2025-06-12 |
| AGIO | Director | 6,549 | $29.46 | $192.9K | $0 | 12 | 2022-06-23 |
| BIIB | Executive VP and CFO | 10,813 | $200.05 | $2.16M | -$48.55M | 55 | 2017-04-27 |
Recent Filings
132 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | INCY | Grant (A) | +1,642 | $0 | EDGAR |
| 2026-05-21 | INCY | Mixed | — | -$156.0K | EDGAR |
| 2026-04-02 | INCY | Grant (A) | +265 | $24.9K | EDGAR |
| 2026-03-23 | EXACT SCIENCES CORP (EXAS) Delisted | Disp (D) | −26,038 | $0 | EDGAR |
| 2026-01-05 | INCY | Grant (A) | +241 | $23.8K | EDGAR |
| 2025-10-02 | INCY | Grant (A) | +285 | $24.2K | EDGAR |
| 2025-07-02 | INCY | Grant (A) | +361 | $24.6K | EDGAR |
| 2025-06-16 | SION | Grant (A) | — | $0 | EDGAR |
| 2025-06-16 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +5,398 | $0 | EDGAR |
| 2025-06-12 | INCY | Grant (A) | +2,518 | $0 | EDGAR |